Jagsonpal Pharmaceuticals Limited
Share Price Target & Analysis

NSE:JAGSNPHARM

200.14

VWAP

202.89

Open

202.02

Close

206

High

198.01

Low

301.65

52 Week High

199.20 ⇩
-2.82 (-1.4%)

JAGSNPHARM

(PHARMA)
30.1% Momentum

Turnaround Potential

155

52 Week Low

6.09

EPS

40.62

PE

5.07

PB

Economical
Quality

Gold
Valuation

#Analysis

NSE: JAGSNPHARM Share Price Financial Analysis & Valuation

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical. It is one of Micro Cap company with Market Capitalization of Rs 423.1 (in Cr). Total number of free float shares are 2.6 (in Lacs). Jagsonpal Pharmaceuticals Limited is listed on NSE with Exchange ID - INE048B01035 and trading code is NSE:JAGSNPHARM with short name JagsonpalPharma.

In the past 1 year, Jagsonpal Pharmaceuticals Limited has declared an equity dividend of Rs 4 per share. At the current share price of JAGSNPHARM at Rs 199.20, this results in a dividend yield of 2.01 %.

As per the Fundamental Analysis of NSE:JAGSNPHARM, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine JAGSNPHARM underlying value and future prospects. All of this data is available in JAGSNPHARM financial statements.

Quality of the Stock: As per the fundamental analysis of NSE:JAGSNPHARM, it is clearly understood that JAGSNPHARM is Economical performer in terms of earnings and profit margins with an EPS of 6.09. NSE:JAGSNPHARM book value per share as of today is 39.31. The current price to book ratio for JAGSNPHARM as of Apr 24, 2026 is 5.07.

Valuation of the Stock: The current valuation of JAGSNPHARM stock is like Gold which means currently the stock is Overpriced. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of JAGSNPHARM whether to BUY this stock at current valuation. The delivery percentage of JAGSNPHARM is 44.27% is very crucial parameter which shows that 44.27% investors are anticipating that the price of JAGSNPHARM share should go up with VWAP at 200.14.

Now, the main question is whether to BUY or SELL, NSE:JAGSNPHARM at current valuation.
As per latest Analysis No. #1191:-

⇑ STRONG BUY JAGSNPHARM if All Greens

⇗ BUY JAGSNPHARM (at Lower Levels) if any 2 Greens

⇒ NEUTRAL or HOLD JAGSNPHARM (With Stop Loss) if only 1 Green

⇘ SELL JAGSNPHARM if NO Green Indicator

NSE: JAGSNPHARM Share Price Today (Apr 24, 2026)

(Jagsonpal Pharmaceuticals Limited Daily Analysis on the basis of JAGSNPHARM Intraday Graph & Trend)

Jagsonpal Pharmaceuticals Limited share price moved Down by -1.4% from its previous close of Rs 202.02. JAGSNPHARM stock last traded price is 199.20. JAGSNPHARM share price trend is Down with a total of 123410 stocks traded till now. It has touched an intraday high of Rs 206 and an intraday low of Rs 198.01. The JAGSNPHARM trading at 199.20, Down by Rs. -2.82, or -1.4 percent which suggests that most of the Traders are anticipating that the price of JAGSNPHARM share should go Down.

NSE: JAGSNPHARM Share Price Tomorrow Prediction

(Jagsonpal Pharmaceuticals Limited Share Price Prediction for Tomorrow & future forecast is based on Current Trend of JAGSNPHARM)

Jagsonpal Pharmaceuticals Limited share price moved Down by -1.4%. JAGSNPHARM share price short term trend is Down. It suggests that JAGSNPHARM Share Price for Tomorrow remains the same with VWAP at 200.14 will be treated as stop loss for intraday traders. Jagsonpal Pharmaceuticals Limited Long term investors can follow the JAGSNPHARM long term trend as mentiond in future forecast table.

NSE Code

NSE: JAGSNPHARM

JAGSNPHARM Share Price Today

 199.20

JAGSNPHARM Share Price Target Prediction for 2026 ^

 162.5 - 242.6

JAGSNPHARM Share Price Target Prediction for 2027*^

 242.6 - 322.9

JAGSNPHARM Share Price Target Prediction for 2028*^

 322.9 - 345.5

JAGSNPHARM Share Price Target Prediction for 2029*^

 363

JAGSNPHARM Share Price Target Prediction for 2030*^

 373

JAGSNPHARM Share Price Target Prediction for 2035*^

 407
JAGSNPHARM Current Book Value 2025
39.1

*Jagsonpal Pharmaceuticals Limited Short Term & Long Term share price target is based on current financial year earings of the company.
^JAGSNPHARM share price target prediction for 2025 2026 2027 to 2030 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.

JAGSNPHARM Technical Analysis

Candlestick Pattern: @242.09

JAGSNPHARM Moving Averages

BUY (14) NEUTRAL (0) SELL (0)
MA Simple Action S1 Expo Action E2
MA_5 232.65 BUY 233.93 BUY
MA_12 227.82 BUY 229.75 BUY
MA_20 225.18 BUY 228.36 BUY
MA_32 228.69 BUY 227.05 BUY
MA_50 225.32 BUY 226.3 BUY
MA_100 222.47 BUY 225.25 BUY
MA_200 225.94 BUY 216.1 BUY

JAGSNPHARM Trend Oscillators

BUY (3) NEUTRAL (1) SELL (0)
Trend Oscillators Value Action
Bollinger Bands 239.31 OverBought
MACD 1.56 BUY
ADX 12.83 NO or Weak Trend
DMI (+/-) 28.33 / 12.76 Uptrend

JAGSNPHARM Momentum Oscillators

BUY (7) NEUTRAL (5) SELL (0)
Momentum Oscillators Value Action
RSI 66.74 Neutral
STOCHASTIC_K (Fast) 68.02 Neutral
STOCHASTIC_D (Slow) 63.92 Neutral
CCI 167.98 BUY
PSAR 215.74 BUY
TRUE RANGE 23 BUY
ATR 8.63 BUY
WILLIAMS R -18.43 Overbought
TRIX 0 Neutral
STOCHASTIC RSI K 100 Overbought
STOCHASTIC RSI D 59.83 Neutral
MOMENTUM 7.07 BUY

JAGSNPHARM Last 1 Year Trend

Duration Value
1 Year 79.57%
3 Months 19.33%
1 Month 3.01%
1 Week 4.76%

JAGSNPHARM Technical Analysis Summary

Updated on 2025-07-11
Action Overall (%)
BUY 80%
NEUTRAL / HOLD 20%
SELL 0%

Most popular Questions & Answers about JAGSNPHARM


Jagsonpal Pharmaceuticals Limited stock last traded price is 199.20. JAGSNPHARM share price moved Down by -1.4% from its previous close of Rs 202.02.

Jagsonpal Pharmaceuticals Limited share price trend is Down with a total of 123410 stocks traded till now. It has touched an intraday high of Rs 304.6665 and an intraday low of Rs 198.01. The JAGSNPHARM trading at 199.20, Down by Rs. -2.82, or -1.4 percent which suggests that most of the Traders are anticipating that the price of JAGSNPHARM share should go Down and the Stop Loss will be around 200.14.

The market cap of Jagsonpal Pharmaceuticals Limited is ₹423.1 (in Cr) as of Apr 23, 2026.

The current price to earning ratio for Jagsonpal Pharmaceuticals Limited as of Apr 23, 2026 is 40.62.

The current price to book ratio for Jagsonpal Pharmaceuticals Limited as of Apr 23, 2026 is 5.07.

The highest price of Jagsonpal Pharmaceuticals Limited stock is ₹301.65 in the last 52-week.

The lowest price of Jagsonpal Pharmaceuticals Limited stock is ₹155 in the last 52-week.

Jagsonpal Pharmaceuticals Limited share trading at ₹199.20, Down by Rs. -2.82, or -1.4 percent which suggests that most of the traders are anticipating that the price of JAGSNPHARM share should go Down.

In 2025, Stock price target for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) are ₹162.5 on downside and ₹242.6 on upside. Jagsonpal Pharmaceuticals Limited share price target is based on current financial year earings of the company.

In 2026, Stock price target for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) are ₹242.6 on downside and ₹322.9 on upside. Jagsonpal Pharmaceuticals Limited share price target is based on forecasted future earnings of the company.

In 2027, Stock price target for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) are ₹322.9 on downside and ₹345.5 on upside. Jagsonpal Pharmaceuticals Limited share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.

In next five years, Stock price target for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) will be around ₹373 Jagsonpal Pharmaceuticals Limited share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of JAGSNPHARM.

The price of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) shares moved by -1.4%. The short-term trend for JAGSNPHARM share price is Down. It implies that the share price of JAGSNPHARM will stay the same tomorrow and that intraday traders should treat VWAP at 200.14 as a stop loss. Investors with a long-term outlook can track JAGSNPHARM long-term trajectory, which is indicated in the future forecast table.

Estimated DCF Value of JAGSNPHARM stock is 73. Compared to the current market price of 199.20 INR, the JAGSNPHARM stock is Overvalued by 63.4%.

As per the fundamental analysis of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM), it is of Economical quality in terms of earnings and profit margins with an EPS of 6.09. Jagsonpal Pharmaceuticals Limited book value per share as of today is 39.31. The current price to book ratio for JAGSNPHARM as of Apr 24, 2026 is 5.07.


NSE:JAGSNPHARM News & Other Useful Information about JAGSNPHARM Share Price


Peer Comparison of NSE: JAGSNPHARM

The Peers list includes companies operating in the same industry and having comparable market cap.

Sector: Pharmaceuticals

Company Price EPS BV
SUNPHARMA 1620.40 16.77 102.19
DIVISLAB 6361.50 94.85 600.79
MEDICAMEQ 257.66 6.52 202.47
CIPLA 1295.00 57.14 419.19
DRREDDY 1317.10 55.59 378.64
PGHH 5215.00 189.8 373.34
TORNTPHARM 4117.20 64.97 266.87
BIOCON 349.85 0.05 99.01
LUPIN 2296.10 120.18 611.19
ALKEM 5235.00 195.87 1194.91
Updated at: 24 Apr 2026 15:56

Feel free to contact us, in case of any queries.

SITEMAP 8503
Disclaimer: Published information or data available on the Website may not be current or up to date and also any information or data available on this website may contain inaccuracies and/or typographical errors. Kindly refer any reliable source for its accuracy. If you select any of these stocks for your trades, you do so at your own risk.

Stocks to Watch Today

ADANIENT 2287.60 -12.40 (-0.54%) | ADANIGREEN 1235.80 21.65 (1.78%) | ADANIPORTS 1585.10 -17.80 (-1.11%) | ADANITRANS 988.50 0.35 (0.04%) | AMBUJACEM 451.20 0.80 (0.18%) | APOLLOHOSP 7732.50 -48.50 (-0.62%) | ASIANPAINT 2485.10 -36.30 (-1.44%) | ATGL 626.85 5.15 (0.83%) | AUROPHARMA 1413.80 -21.60 (-1.5%) | AXISBANK 1365.90 -3.70 (-0.27%) | BAJAJ-AUTO 9576.00 25.50 (0.27%) | BAJAJFINSV 1770.70 -21.90 (-1.22%) | BAJFINANCE 921.55 3.20 (0.35%) | BALKRISIND 2225.40 -40.00 (-1.77%) | BANDHANBNK 174.67 0.77 (0.44%) | BANKBARODA 274.13 -2.21 (-0.8%) | BEL 444.45 -5.50 (-1.22%) | BERGEPAINT 460.40 -8.25 (-1.76%) | BHARTIARTL 1814.50 -26.70 (-1.45%) | BIOCON 349.85 -8.15 (-2.28%) | BOSCHLTD 36690.00 -690.00 (-1.85%) | BPCL 308.10 -1.70 (-0.55%) | BRITANNIA 5730.50 59.00 (1.04%) | CADILAHC 905.25 2.35 (0.26%) | CIPLA 1295.00 -10.90 (-0.83%) | COALINDIA 456.00 5.35 (1.19%) | COLPAL 2171.30 21.10 (0.98%) | DABUR 451.10 -8.90 (-1.93%) | DIVISLAB 6361.50 -17.00 (-0.27%) | DLF 587.05 -5.75 (-0.97%) | DMART 4443.50 -77.70 (-1.72%) | DRREDDY 1317.10 -13.90 (-1.04%) | EICHERMOT 7111.50 19.00 (0.27%) | GAIL 165.61 0.65 (0.39%) | GLAND 1713.50 -81.90 (-4.56%) | GODREJCP 1089.90 -53.05 (-4.64%) | GRASIM 2739.30 4.30 (0.16%) | GUJGASLTD 383.85 -2.15 (-0.56%) | HAVELLS 1238.60 -21.70 (-1.72%) | HCLTECH 1203.20 -74.40 (-5.82%) | HDFC 2724.30 0.00 (0%) | HDFCAMC 2735.00 26.80 (0.99%) | HDFCBANK 784.85 0.50 (0.06%) | HDFCLIFE 588.20 -10.45 (-1.75%) | HEROMOTOCO 4961.50 -70.50 (-1.4%) | HINDALCO 1048.35 7.00 (0.67%) | HINDUNILVR 2327.30 -39.10 (-1.65%) | HINDZINC 588.50 -3.60 (-0.61%) | ICICIBANK 1326.20 -21.80 (-1.62%) | ICICIGI 1772.10 -37.80 (-2.09%) | ICICIPRULI 514.20 -21.10 (-3.94%) | INDIGO 4523.10 -32.90 (-0.72%) | INDUSINDBK 847.95 -12.40 (-1.44%) | INDUSTOWER 402.20 -2.50 (-0.62%) | INFY 1154.60 -86.00 (-6.93%) | IOB 35.01 -0.13 (-0.37%) | IOC 143.47 -2.01 (-1.38%) | ITC 301.60 -3.70 (-1.21%) | JSWSTEEL 1255.70 -1.30 (-0.1%) | KOTAKBANK 370.85 0.45 (0.12%) | LT 4014.30 -39.80 (-0.98%) | LTI 5706.50 -337.50 (-5.58%) | LUPIN 2296.10 -45.30 (-1.93%) | M&M 3038.40 -9.30 (-0.31%) | MARICO 783.30 4.40 (0.56%) | MARUTI 13048.00 -112.00 (-0.85%) | MCDOWELL-N 1358.10 -8.00 (-0.59%) | MOTHERSUMI 121.00 -1.62 (-1.32%) | MUTHOOTFIN 3493.50 -67.90 (-1.91%) | NAUKRI 984.95 -33.10 (-3.25%) | NESTLEIND 1421.30 10.80 (0.77%) | NMDC 89.29 1.98 (2.27%) | NTPC 401.85 -0.40 (-0.1%) | ONGC 284.80 -1.45 (-0.51%) | PEL 1124.20 0.00 (0%) | PIDILITIND 1394.30 -7.80 (-0.56%) | PIIND 3081.20 11.60 (0.38%) | PNB 113.09 0.38 (0.34%) | POWERGRID 316.40 -2.75 (-0.86%) | RELIANCE 1327.80 -15.60 (-1.16%) | SAIL 178.46 2.01 (1.14%) | SBICARD 670.30 -10.25 (-1.51%) | SBILIFE 1768.90 -59.20 (-3.24%) | SBIN 1101.10 6.85 (0.63%) | SHREECEM 24950.00 -520.00 (-2.04%) | SIEMENS 3808.90 -55.50 (-1.44%) | SRF 2493.60 -48.80 (-1.92%) | SUNPHARMA 1620.40 -59.70 (-3.55%) | TATACONSUM 1174.00 -10.40 (-0.88%) | TATAMOTORS 375.45 3.40 (0.91%) | TATAMTRDVR 768.65 33.35 (4.54%) | TATASTEEL 210.07 -0.84 (-0.4%) | TCS 2396.90 -124.90 (-4.95%) | TECHM 1358.50 -63.00 (-4.43%) | TITAN 4410.00 -46.50 (-1.04%) | TORNTPHARM 4117.20 -30.00 (-0.72%) | ULTRACEMCO 11998.00 -169.00 (-1.39%) | UPL 631.40 -10.65 (-1.66%) | VEDL 720.95 -14.65 (-1.99%) | WIPRO 199.36 -3.40 (-1.68%) |